Skip to content
MEO NextGenDeveloper StudioDEV
  1. Dashboard
  2. Questions
  3. SBA
  4. Q361
SBA

SBA — Single Best Answer · Review

Question 361

Physiology → Haematology

NextGen Workflow Status Needs Review
SQL status generated
Destination Site
Type SSBA
UUID 565d7e84-a743-4ec7-aa76-59512d280177

Classification

Speciality
Obstetrics and Gynaecology
Group
Basic
Title
Physiology
Topic
Haematology
Subtopic 1
Blood coagulation
Subtopic 2
Haemophilia A
Subtopic 3
Inheritance and haemostasis — Treatment
Question Type
SBA

Question

SSBA
Question Header
A patient with an inherited coagulation disorder has normal initial haemostasis but subsequently develops persistent oozing when vascular spasm wears off.
Question Stem
Which combination best identifies the disorder and its treatment?

Options

A Autosomal dominant factor VII deficiency treated with vitamin K
B X-linked recessive factor IX deficiency treated with platelet transfusion
C X-linked recessive factor VIII deficiency treated by supplying factor VIII
D Autosomal recessive factor V deficiency treated with factor VII
E X-linked dominant platelet disorder treated with factor XIII

Explanation

Haemophilia A is associated with a recessive abnormality of the X chromosome and deficiency of factor VIII, affecting the intrinsic pathway. Initial haemostasis due to vascular closure is preserved, so bleeding time is normal, but failure of clotting becomes apparent as persistent oozing after vascular spasm wears off. Treatment is replacement of the missing factor VIII.

Option Validity

A) Haemophilia A is associated with an X-linked recessive abnormality and factor VIII deficiency, not an autosomal dominant factor VII disorder.

B) The described Haemophilia A defect is factor VIII deficiency; platelet transfusion does not replace the missing coagulation factor.

D) Factor V deficiency does not correspond to the described X-linked factor VIII disorder or its treatment.

E) Haemophilia A is a coagulation-factor deficiency rather than an X-linked dominant platelet disorder, and treatment is replacement of factor VIII.

Further Reading

Saxena. Textbook for MRCOG-1. Physiology - Haematology - Haemophilia A, p.72.

Source & metrics

Authored Difficulty
5.00
Evaluation Score
—
Destination
Site
Source
—
Source Section
—
Source Locator
—
Updated
2026-10-06 01:57:35
Difficulty Factor
Not available yet
Attended Users
No candidate-attempt data yet
Review Question